Type 2 diabetes mellitus and post-colonoscopy colorectal cancer: Clinical and molecular characteristics and survival

Abstract

Abstract Purpose Studies suggest that patients with type 2 diabetes mellitus (T2D) may be at increased risk of post-colonoscopy colorectal cancer (PCCRC). We investigated clinical and molecular characteristics and survival of T2D patients with PCCRC to elucidate how T2D-related PCCRC may arise. Methods We identified T2D patients with colorectal cancer (CRC) from 1995 to 2015 and computed prevalence ratios (PRs) comparing clinical and molecular characteristics of CRC in T2D patients with PCCRC vs. in T2D patients with colonoscopy-detected CRC (dCRC). We also followed T2D patients from the diagnosis of PCCRC/dCRC until death, emigration, or study end and compared mortality using Cox-proportional hazards regression models adjusted for sex, age, year of CRC diagnosis, and CRC stage. Results Compared with dCRC, PCCRC was associated with a higher prevalence of proximal CRCs (54% vs. 40%; PR: 1.43, 95% confidence interval [CI]: 1.27–1.62) in T2D patients. We found no difference between PCCRC vs. dCRC for CRC stage, histology, and mismatch repair status. The proportion of CRCs that could be categorized as PCCRC decreased over time. Within one year after CRC, 63% of PCCRC vs. 78% of dCRC patients were alive (hazard ratio [HR]: 1.85 [95% CI: 1.47–2.31]). Within five years after CRC, 44% of PCCRC vs. 54% of dCRC patients were still alive (HR: 1.44 [95% CI: 1.11–1.87]). Conclusion The increased prevalence of proximally located PCCRCs and the poorer survival may suggest overlooked colorectal lesions, as well as changed or rapid tumor progression as explanations for T2D-related PCCRC.